Baxter International Inc. Plans Quarterly Dividend of $0.01 (NYSE:BAX)

Baxter International Inc. (NYSE:BAX) announced a quarterly dividend on Thursday, February 12th. Shareholders of record on Friday, February 27th will be given a dividend of 0.01 per share by the medical instruments supplier on Wednesday, April 1st. This represents a c) annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, February 27th.

Baxter International has increased its dividend by an average of 0.0%per year over the last three years. Baxter International has a payout ratio of 1.5% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Baxter International to earn $2.73 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 1.5%.

Baxter International Stock Performance

NYSE:BAX opened at $18.71 on Friday. The firm’s 50-day moving average is $19.77 and its 200-day moving average is $21.32. The company has a market cap of $9.62 billion, a price-to-earnings ratio of -28.34, a PEG ratio of 1.29 and a beta of 0.59. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.18 and a current ratio of 1.84. Baxter International has a 52-week low of $17.40 and a 52-week high of $37.74.

Baxter International (NYSE:BAX) last released its earnings results on Thursday, February 12th. The medical instruments supplier reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.53 by ($0.09). Baxter International had a negative net margin of 3.09% and a positive return on equity of 17.38%. The company had revenue of $2.97 billion during the quarter, compared to the consensus estimate of $2.82 billion. During the same quarter in the previous year, the business posted $0.58 EPS. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.850-2.050 EPS. Equities research analysts anticipate that Baxter International will post 2.48 earnings per share for the current year.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.